Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 2Phase 2 1Phase 1/2 1Phase 1 1

Status

Recruiting 5Active not recruiting 2Completed 1

Sponsor Class

OTHER 5INDUSTRY 2NETWORK 1

Study Type

Interventional 8Observational 1

Sponsor

Cancer Type

Genitourinary 8

Conditions

Breast Neoplasms 2400Neoplasms 1819Carcinoma, Non-Small-Cell Lung 1599Prostatic Neoplasms 1298Colorectal Neoplasms 1140Lung Neoplasms 984Neoplasm Metastasis 830Multiple Myeloma 792Leukemia, Myeloid, Acute 767Ovarian Neoplasms 674Pancreatic Neoplasms 662Melanoma 660Squamous Cell Carcinoma of Head and Neck 586Carcinoma, Hepatocellular 567Recurrence 562Brain Neoplasms 527Glioblastoma 513Head and Neck Neoplasms 500Stomach Neoplasms 497Triple Negative Breast Neoplasms 465Lymphoma 454Uterine Cervical Neoplasms 450Carcinoma, Renal Cell 425Precursor Cell Lymphoblastic Leukemia-Lymphoma 410Lymphoma, Non-Hodgkin 389Endometrial Neoplasms 381Sarcoma 368Lymphoma, Follicular 356Urinary Bladder Neoplasms 354Hematologic Neoplasms 352

Interventions

Radiosurgery 3Androgen Antagonists 3Prednisone 2Docetaxel 2Abiraterone Acetate 2fludrocortisone acetate 1enzalutamide 1darolutamide 1apalutamide 1Standard of Care 1Radiotherapy, Image-Guided 1Radiotherapy 1Pluvicto 1Midazolam 1Lutetium-177 1Lutetium 1Hydrocortisone 1Gonadotropin-Releasing Hormone 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Interventional × Prostate Cancer Metastatic × 1 year × Clear all
NCT06136624 2026-05-05

OMAHA-003

Merck Sharp & Dohme LLC

Phase 3 Recruiting
1,310 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT04916613 2026-04-28

GETUG-AFU 40

UNICANCER

Phase 3 Recruiting
300 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT02913196 2026-04-20

Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC

Weill Medical College of Cornell University

Phase 1 Completed
16 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT05457699 2026-04-08

ANCHORProstate

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 2 Recruiting
80 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT03784755 2026-03-27

PLATON

Canadian Cancer Trials Group

Phase NA Active not recruiting
409 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT04983095 2026-02-17

METRO

Umeå University

Phase NA Recruiting
118 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT06320067 2025-09-26

STAMPEDE2

University College, London

Phase 3 Recruiting
3,360 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT03436485 2025-07-22

CYPIDES

Orion Corporation, Orion Pharma

Phase 1/2 Active not recruiting
204 enrolled
Genitourinary

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡